Anabolic Androgenic Steroids Persistently Modify the User's Lipid Profile: a Case Report
Abstract
The aim of the study was to show a lasting modification of the lipid profile and atherogenic indices by the abuse of anabolic androgenic steroids (AAS) by a amateur bodybuilder. This study reports a case of a 27-year-old non-competitive bodybuilder with severe abnormalities in lipid profile and atherogenic indices. He used anabolic androgenic steroids and had no other risk factors for heart disease or associated risk factors. After some educational lectures, he decided to continue his training without using anabolic androgenic steroids or any illegal ergogenic drugs. Lipid profile and atherogenic indices returned to normal values in the third laboratory test performed five years after her last cycle of AAS. Abusing anabolic androgenic steroids can promote increased risk of cardiovascular disease, a trait that can persist for many years after even after discontinuing anabolic androgenic steroid use.
References
Ahlgrim, C., & Guglin, M. (2009). Anabolics and cardiomyopathy in a bodybuilder: case report and literature review. Journal of cardiac failure, 15(6), 496-500. https://doi.org/10.1016/j.cardfail.2008.12.014
Ajayi, A.A., Mathur, R., & Halushka, P.V. (1995). Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation, 91(11), 2742-2747. https://doi.org/10.1161/01.CIR.91.11.2742
Angell, P., Chester, N., Green, D., Somauroo, J., Whyte, G., & George, K. (2012). Anabolic steroids and cardiovascular risk. Sports medicine, 42(2), 119-134. https://goo.gl/LR4H8V
Baggish, AL, Weiner, RB, Kanayama, G., Hudson, JI, Picard, MH, Hutter Jr, AM, & Pope Jr, HG (2010). Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circulation: Heart Failure, 3(4), 472-476. https://doi.org/10.1161/CIRCHEARTFAILURE.109.931063
Basaria, S., Wahlstrom, J.T., & Dobs, A.S. (2001). Anabolic-androgenic steroid therapy in the treatment of chronic diseases. The Journal of Clinical Endocrinology & Metabolism, 86(11), 5108-5117. https://doi.org/10.1210/jcem.86.11.7983
Blue, J.G., & Lombardo, J.A. (1999). Steroids and steroid-like compounds. Clinics in Sports Medicine, 18(3), 667-689. https://doi.org/10.1016/S0278-5919(05)70175-7
Castelli, W.P., Garrison, R.J., Wilson, P.W., Abbott, R.D., Kalousdian, S., & Kannel, W.B. (1986). Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. Jama, 256(20), 2835-2838. https://doi.org/10.1001jama.1986.03380200073024
Dobiasova, M., Urbanova, Z., & Samanek, M. (2005). Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiol Res, 54(159), e65. http://www.biomed.cas.cz/physiolres/pdf/54/54_159.pdf
Far, H.R.M., Ågren, G., & Thiblin, I. (2012). Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings. Cardiovascular Pathology, 21(4), 312-316. https://doi.org/10.1016/j.carpath.2011.10.002
Fernandez, M.L., & Webb, D. (2008). The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. Journal of the American College of Nutrition, 27(1), 1-5. https://doi.org/10.1080/07315724.2008.10719668
Gårevik, N., Strahm, E., Garle, M., Lundmark, J., Ståhle, L., Ekström, L., & Rane, A. (2011). Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids. The Journal of steroid biochemistry and molecular biology, 127(3-5), 295-300. https://doi.org/10.1016/j.jsbmb.2011.08.005
Gårevik, N., Rane, A., Björkhem-Bergman, L., Ekström, L. (2014). Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men. Substance Abuse and Rehabilitation, 5, 121-127. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266340/.
Glazer, G. (1991). Atherogenic effects of anabolic steroids on serum lipid levels: a literature review. Archives of internal medicine, 151(10), 1925-1933. https://doi.org/10.1001/archinte.1991.00400100013003
Hengevoss, J., Piechotta, M., Müller, D., Hanft, F., Parr, MK Schänzer, W., Diel, P. (2015). Combined effects of androgen anabolic steroids and physical activity on the hypothalamic-pituitary-gonadal axis. Journal of Steroid Biochemistry and Molecular Biology, 150, 86–96. http://dx.doi.org/10.1016/j.jsbmb.2015.03.003.
Henning, A. (2017). Challenges to promoting health for amateur athletes through anti-doping policy. Drugs: Education, prevention and policy, 24(3), 306-313. https://doi.org/10.1080/09687637.2016.1208732
Hislop, M.S., Ratanjee, B.D., Soule, S.G., & Marais, A.D. (1999). Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men. European journal of endocrinology, 141(1), 40-46. https://doi.org/10.1530/eje.0.1410040.
Ip, E.J., Barnett, M.J., Tenerowicz, M.J., & Perry, P.J. (2011). The Anabolic 500 survey: Characteristics of male users versus nonusers of anabolic‐androgenic steroids for strength training. Pharmacotherapy: The journal of human pharmacology and drug therapy, 31(8), 757-766. https://doi.org/10.1592/phco.31.8.757
Irwig, MS, Fleseriu, M., Jonklaas, J., Tritos, NA, Yuen, KCJ, Correa, R., Elhomsy, G., Gaarla, V., Jsaim, S., Soe, K., Baldeweg, SE, Boguszewski, CL, & Bancos, I. (2020). Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem. Endocrine Practice, 26(3), 340–353. https://doi.org/10.4158/ps-2019-0540
Kanayama, G., & Pope Jr, H.G. (2018). History and epidemiology of anabolic androgens in athletes and non-athletes. Molecular and Cellular Endocrinology, 464, 4-13. https://doi.org/10.1016/j.mce.2017.02.039
Karila, T., Laaksonen, R., Jokelainen, K., Himberg, J.J., & Seppälä, T. (1996). The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers. Metabolism, 45(7), 844-847. https://doi.org/10.1016/S0026-0495(96)90157-2
Leit, R.A., Pope Jr, H.G., & Gray, J.J. (2001). Cultural expectations of muscularity in men: The evolution of Playgirl centerfolds. International Journal of eating disorders, 29(1), 90-93. https://psycnet.apa.org/record/2001-16082-015
Maravelias, C., Dona, A., Stefanidou, M., & Spiliopoulou, C. (2005). Adverse effects of anabolic steroids in athletes: a constant threat. Toxicology letters, 158(3), 167-175. https://doi.org/10.1016/j.toxlet.2005.06.005
Mann, S., Beedie, C., & Jimenez, A. (2014). Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Medicine, 44(2), 211–221. https://doi.org/10.1007/s40279-013-0110-5
Marqueti, R.C., Micocci, K.C., Leite, R.D., & Selistre-de-Araujo, H.S. (2012). Nandrolone inhibits MMP-2 in the left ventricle of rats. International journal of sports medicine, 33(03), 181-185. https://doi.org/10.1055/s-0031-1291252
Millán, J., Pintó, X., Muñoz, A., Zúñiga, M., Rubiés-Prat, J., Pallardo, LF, Masana, L, Mangas, A, Hernández-Mijares, A, González-Santos, P, Ascaso, JF, & Pedro-Botet, J. (2009). Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vascular health and risk management, 5, 757. https://doi.org/10.2147/VHRM.S6269
Montisci, M., El Mazloum, R., Cecchetto, G., Terranova, C., Ferrara, SD, Thiene, G., & Basso, C. (2012). Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic science international, 217(1-3), e13-e18. https://doi.org/10.1016/j.forsciint.2011.10.032
Nieminen, MS, Rämö, MP, Viitasalo, M., Heikkilä, P., Karjalainen, J., Mäntysaari, M., & Heikkila, J. (1996). Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. European heart journal, 17(10), 1576-1583. https://doi.org/10.1093/oxfordjournals.eurheartj.a014724
Nwagha, U.I., Ikekpeazu, E.J., Ejezie, F.E., Neboh, E.E., & Maduka, I. (2010). Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. African health sciences, 10(3). https://goo.gl/UoXHkP
Palacios, A., Campfield, L.A., McClure, R.D., Steiner, B., & Swerdloff, R.S. (1983). Effect of testosterone enanthate on hematopoiesis in normal men. Fertility and Sterility, 40(1), 100-104. https://doi.org/10.1016/S0015-0282(16)47185-2
Parkinson, A.B., & Evans, N.A. (2006). Anabolic androgenic steroids: a survey of 500 users. Medicine and science in sports and exercise, 38(4), 644-651. https://doi.org/10.1249/01.mss.0000210194.56834.5d
Pertusi, R., Dickerman, R.D., & McConathy, W.J. (2001). Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis? The Journal of the American Osteopathic Association, 101(7), 391-394. https://goo.gl/Vfrfta
Pettersson, J., Hindorf, U., Persson, P., Bengtsson, T., Malmqvist, U., Werkström, V., & Ekelund, M. (2008). Muscular exercise can cause highly pathological liver function tests in healthy men. British journal of clinical pharmacology, 65(2), 253-259. https://doi.org/10.1111/j.1365-2125.2007.03001.x
Pope, H.G., Kouri, E.M., & Hudson, J.I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Archives of general psychiatry, 57(2), 133-140. https://doi.org/10.1001/archpsyc.57.2.133
Pope Jr, H.G., Olivardia, R., Gruber, A., & Borowiecki, J. (1999). Evolving ideals of male body image as seen through action toys. International journal of eating disorders, 26(1), 65-72. https://doi.org/10.1002/(sici)1098-108x(199907)26:1%3C65::aid-eat8%3E3.0.co;2-d
Sagoe, D., Molde, H., Andreassen, C.S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of epidemiology, 24(5), 383-398. https://doi.org/10.1016/j.annepidem.2014.01.009
Santamarina, R.D., Besocke, A.G., Romano, L.M., Ioli, P.L., & Gonorazky, S.E. (2008). Ischemic stroke related to anabolic abuse. Clinical neuropharmacology, 31(2), 80-85. https://doi.org/10.1097/WNF.0b013e3180ed4485
Santora, LJ, Marin, J., Vangrow, J., Minegar, C., Robinson, M., Mora, J., & Frieds, G. (2006). Coronary calcification in body builders using anabolic steroids. Preventive cardiology, 9(4), 198-201. https://doi.org/10.1111/j.1559-4564.2006.05210.x
Schmidt, W., Biermann, B., Winchenbach, P., Lison, S., & Boning, D. (2000). How valid is the determination of hematocrit values to detect blood manipulations?. International journal of sports medicine, 21(2), 133-138. https://doi.org/10.1055/s-2000-8871.
Schwingel, PA, Cotrim, HP, Salles, BR, Almeida, CE, dos Santos Jr, CR, Nachef, B., Andrade, AR, & Zoppi, CC (2011). Anabolic‐androgenic steroids: A possible new risk factor of toxicant‐associated fatty liver disease. Liver International, 31(3), 348-353. https://doi.org/10.1111/j.1478-3231.2010.02346.x
Shahidi, N.T. (1973). Androgens and erythropoiesis. New England Journal of Medicine, 289(2), 72-80. https://doi.org/10.1056/NEJM197307122890205
Urhausen, A., Albers, T., & Kindermann, W. (2004). Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart, 90(5), 496-501. http://dx.doi.org/10.1136/hrt.2003.015719
Veras, K., Silva-Junior, F., L., Lima-Silva, A., E., De-Oliveira, F., R., & Pires, F.O. (2015) Impaired Physical Performance and Clinical Responses after a recreational bodybuilder’s self-administration of steroids: A Case Report. The World Journal of Men’s Health, 33(3), 209-213. http://dx.doi.org/10.5534/wjmh.2015.33.3.209
World Health Organization (1995). Physical status: The use of and interpretation of anthropometry, Report of a WHO Expert Committee. World Health Organization. https://doi.org/10.1002/(SICI)1520-6300(1996)8:6<786::AID-AJHB11>3.0.CO;2-I
Author Biographies
http://lattes.cnpq.br/8143521576246390
http://lattes.cnpq.br/7611953102115785
Copyright (c) 2022 Lecturas: Educación Física y Deportes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
